MedTrace Logo

Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database

NCT05419349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1819

Last updated 2022-11-04

No results posted yet for this study

Summary

This study have two aims, the first is to explore the optimal cutoff of TLN for Siewert type II AEG using the Surveillance, Epidemiology, and End Results (SEER) database the second is to provide a more accurate staging for Siewert type II AEG patients.

Conditions

  • Adenocarcinoma of the Esophagogastric Junction

Interventions

PROCEDURE

esophagogastric junction cancer surgery

esophagogastric junction cancer surgery

Sponsors & Collaborators

  • Fujian Medical University Union Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2022-06-07
Completion
2022-06-07

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05419349 on ClinicalTrials.gov